ReviewAnalytical and bioanalytical chemistry2026
MALDI mass spectrometry imaging across spatial scales in toxicology: tissue evidence, cellular heterogeneity, and emerging single-cell opportunities.
Review in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Toxicological responses are inherently spatially heterogeneous, yet conventional analytical strategies generally rely on homogenized samples and therefore provide limited information on where xenobiotics accumulate, which tissue regions or cellular populations are preferentially affected, and how local molecular perturbations relate to pathology and mechanism. Mass spectrometry imaging (MSI) addresses this limitation by enabling label-free, multiplexed, and spatially resolved detection of xenobiotics, metabolites, lipids, peptides, and proteins directly in biological specimens. In this review, we examine the role of MSI in spatial toxicology, with particular emphasis on matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) as a practical core platform for many current tissue-level and emerging cellular-scale toxicology studies. We first discuss why MSI is analytically well suited for spatial toxicology and compare the major MSI platforms in terms of molecular coverage, spatial resolution, and toxicological applicability. We then summarize representative applications at the tissue level, where MSI has already shown clear value in mapping xenobiotic localization, lesion-associated molecular remodeling, and organ-specific toxicity. Next, we discuss cellular-scale MSI and the transition toward true single-cell analysis, emphasizing that current progress is driven more by workflow development, multimodal integration, and computational advances than by routine toxicological deployment. Finally, using per- and polyfluoroalkyl substances as a focused case study, we illustrate how MSI can connect tissue burden, regional bioaccumulation, and localized biochemical response. Overall, MSI is becoming a key analytical framework for mechanistic spatial toxicology, although broader impact will depend on further advances in standardization, annotation confidence, quantification, and multimodal interpretation.
Indexed as
Identifiers
42573751What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.